Impact of HCV Treatment and Depressive Symptoms on Adherence to Haart among HIV–HCV-Coinfected Patients: Results from the Anrs-Co13-Hepavih Cohort | Zendy

Perrine Roux | Zendy; C. Lions | Zendy; Julien Cohen | Zendy; María Winnock | Zendy; Dominique SalmonCéron | Zendy; Firouzé BaniSadr | Zendy; Philippe Sogni | Zendy; Bruno Spire | Zendy; François Dabis | Zendy; Patrizia Carrieri | Zendy

Open Access

Impact of HCV Treatment and Depressive Symptoms on Adherence to Haart among HIV–HCV-Coinfected Patients: Results from the Anrs-Co13-Hepavih Cohort

Author(s) -

Perrine Roux,

C. Lions,

Julien Cohen,

María Winnock,

Dominique SalmonCéron,

Firouzé BaniSadr,

Philippe Sogni,

Bruno Spire,

François Dabis,

Patrizia Carrieri

Publication year - 2013

Publication title -

antiviral therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.747

H-Index - 87

eISSN - 2040-2058

pISSN - 1359-6535

DOI - 10.3851/imp2699

Subject(s) - medicine , hepatitis c , cohort , logistic regression , depression (economics) , population , prospective cohort study , cohort study , coinfection , immunology , human immunodeficiency virus (hiv) , environmental health , economics , macroeconomics

The additional burden of HCV infection in HIV-HCV-coinfected individuals may have some consequences on adherence to HAART. Few studies have explored the pattern of correlates of non-adherence to HAART while simultaneously considering the impact of HCV treatment and depressive symptoms on adherence to HAART. We used longitudinal data to assess factors associated with non-adherence to HAART.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research